Publications by authors named "Jose Javier Pineda Arribas"
Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors).
Ana Echegoyen-Silanes José Javier Pineda-Arribas María Sánchez-Ares Soledad Cameselle-García Beatriz Sobrino
Virchows Arch
March 2023
Cribriform morular thyroid carcinoma (CMTC) is a rare malignant thyroid tumor with a peculiar growth pattern secondary to permanent activation of the WNT/β-catenin pathway. CMTC may be associated with familial adenomatous polyposis or sporadic; it shares morphological features with papillary thyroid carcinoma (PTC) and was considered a variant of PTC in the 2017 WHO classification of tumors of endocrine organs. The new 5th edition of the WHO classification of endocrine and neuroendocrine tumors considered CMTC an independent thyroid neoplasm of uncertain histogenesis.
View Article and Find Full Text PDFClinical characteristics and prognosis of familial nonmedullary thyroid carcinoma.
Joaquín de Carlos Artajo Ana Irigaray Echarri Javier García Torres José Javier Pineda Arribas Ander Ernaga Lorea
Endocrinol Diabetes Nutr (Engl Ed)
April 2022
Article Synopsis
- Familial non-medullary thyroid carcinoma (FNMTC) is a type of thyroid cancer that affects multiple family members, and this study compared it to non-family cases (sporadic carcinoma or SC).
- They looked at 927 patients from 1990 to 2018 and found that FNMTC usually had smaller tumors and more cases that were in more than one place (multifocality) than SC.
- Overall, FNMTC and SC were similar in terms of how they progressed and the outcomes for the patients, even though FNMTC showed some different characteristics.
Clinical characteristics and prognosis of familial nonmedullary thyroid carcinoma.
Joaquín de Carlos Artajo Ana Irigaray Echarri Javier García Torres José Javier Pineda Arribas Ander Ernaga Lorea
Endocrinol Diabetes Nutr (Engl Ed)
September 2021
Article Synopsis
- Familial non-medullary thyroid carcinoma (FNMTC) is when two or more close family members have thyroid cancer, and this study looks at how it compares to regular thyroid cancer (sporadic carcinoma or SC).
- Researchers studied 927 patients from 1990 to 2018 and found that FNMTC had smaller tumors and more cases where multiple tumors showed up in the same patient, but they had similar outcomes in terms of survival and recurrence as SC.
- The study concludes that even though FNMTC tumors are smaller and more spread out in some cases, they don’t seem to be more aggressive or have a worse prognosis than sporadic thyroid cancer.